EUVIMED · CrossrefJournal
Journal of Clinical Oncology
ISSN 0732-183X · American Society of Clinical Oncology (ASCO)
Latest articles
Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial
Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5
Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5
Unanswered Question Regarding CNS Prophylaxis in CD5-Positive Diffuse Large B-Cell Lymphoma
Enhancing Workforce Research Methodology to Match Patients' Need in Contemporary Oncology Practice
Reply to: Unanswered Question Regarding CNS Prophylaxis in CD5-Positive Diffuse Large B-Cell Lymphoma
Brachytherapy Returns to the Brain: The ROADS Trial and a Second Look at Cavity Radiosurgery
Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial
Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index
Eosinophils in Breast Cancer: One for All and All for One
Second Cancer Risk in Female Survivors of Hodgkin Lymphoma: A National Cohort Analysis Across Treatment Eras
Retraction: PIN1, Cholesterol Biosynthesis, and Clinical Outcomes in Urothelial Carcinoma (UC): A Propensity-Weighted Real-World Clinicogenomic Analysis
Patient-Level Evaluation of Optimal Margin Width for Lumpectomy in Ductal Carcinoma In Situ: An Analysis of Patients in the National Cancer Database Special Study
Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies
Dynamic Circulating Tumor DNA Methylation Monitoring Guiding Postoperative Surveillance in Nonmetastatic Colorectal Cancer: A Prospective, Randomized, Phase III FIND Trial
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS / BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial
Randomized Trial of Hypofractionated Postmastectomy Radiation Therapy in Women With Breast Reconstruction (RT CHARM, Alliance A221505)
To Be Loved
P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR –Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape
Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab
RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial
Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Nivolumab/Ipilimumab and Pembrolizumab for All Cancers: Australia's Landmark Tumor-Agnostic Immunotherapy Reimbursement
Reply to: Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab
Reply to: Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
When Industry Payments to Oncologists Influence Cancer Care
Surgery and Tile-Based Radiation Therapy Versus Surgery and Stereotactic Radiation for Newly Diagnosed Brain Metastases: A Randomized, Open-Label, Phase III Trial
Bridging the Gap: From Molecular Residual Disease to Curative Opportunity: Circulating Tumor DNA–Guided Surveillance After Curative Resection for Stage I to III Colorectal Cancer
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2
Volumes
2026 · 2,0502025 · 8,8002024 · 8,1722023 · 8,1202022 · 7,4742021 · 6,4682020 · 7,8602019 · 7,5262018 · 8,2022017 · 7,8552016 · 7,9002015 · 7,4922014 · 7,5792013 · 7,0662012 · 7,4562011 · 6,9222010 · 5,9392009 · 5,3762008 · 5,5462007 · 5,3152006 · 4,9992005 · 5,1232004 · 4,4202003 · 9192002 · 7872001 · 6302000 · 5781999 · 5321998 · 5681997 · 4811996 · 4431995 · 4331994 · 4111993 · 3691992 · 3091991 · 3281990 · 3051989 · 2901988 · 2741987 · 319
EUVIMED